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Abstract This paper reports baseline behavioral and
biological data collected from a cohort of 535 African
American HIV serodiscordant couples enrolled in the Eban
study across four urban metro areas. Data were collected on
(1) the prevalence of risky sexual behaviors that occur
within a couple and with concurrent sexual partners, (2) the
STD prevalence for each member of the couple and (3) the
correlates of STDs in the male partner as well as in the
female partner. Presentation of the sociodemographic
characterization and HIV risk behavior profiles of African
American HIV serodiscordant couples represents an
important initial description of a hidden, vulnerable pop-
ulation. Future research should be conducted with diverse
samples of African American couples (i.e., younger cou-
ples, non-stable couples) to explore other potential corre-
lates of STD prevalence.
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Introduction
Although the HIV/AIDS epidemic in the African American
community continues to be a public health crisis, perhaps one
subgroup that deserves special attention is African American
HIV serodiscordant couples. In the US, HIV transmission
risk reduction efforts for this population have been minimal.
Although data indicate that condoms reduce the annual HIV
transmission among HIV serodiscordant couples by 95%
when used consistently [1], studies report 20–25% of sero-
discordant couples engage in unprotected intercourse [2, 3].
Research also indicates that overall rates of unprotected
intercourse are greater with regular partners than with non-
regular partners. The rationale for these practices is unclear,
but one study conducted by Wyatt et al. [4], with African
American and Caucasian HIV serodiscordant couples
reported that couples in this study perceived being at a low
risk for HIV transmission and avoided discussing safer sex so
as not to remind the infected partner of their HIV status [5].
The findings from these studies suggest significant risks for
transmission of HIV in HIV serodiscordant couples. Fur-
thermore, HIV acquisition and transmission in serodiscor-
dant couples may be facilitated by sexually transmitted
infections [6]. While several articles have examined the
prevalence of STDs in HIV-infected women [7, 8] and men
who have sex with men [9, 10], the prevalence of STDs and
sexual risk behaviors is incompletely characterized among
African American HIV serodiscordant couples. The present
manuscript aims to address this gap by describing: (1) the
prevalence of risky sexual behaviors that occur within a
couple and that occur with concurrent sexual partners, (2) the
STD prevalence for each member of the couple and (3) the
correlates of STDs in the male partner as well as in the female
partner. The provision of couples-based data, the opportunity
to examine sexual behaviors from both the male and female




A total of 4,389 individuals were pre-screened for possible
inclusion into the study. The following are the top five
reasons individuals were ineligible: 1,006 (23%) reported
no incidents of unprotected intercourse in the past 90 days;
623 (14%) were sero-concordant couples; 543 (12%) could
not be contacted for further screening; 328 (8%) did not
have a partner; and 296 (7%) reported violence in their
Randy Shine, MPH - Penn
Ralph Stevenson, MA - Penn
Robert Tate, M.Ed. - Penn
Michael Taylor, MSW - Penn
Charlotte Wroton, MS - Penn
Recruiters Derryck Griffith - Columbia
Pearl Johnson - Columbia
Lisa Matthews - MPH, EdD Candidate - Columbia
Rhonda Mendoza - Columbia
Allan Winkle - Columbia
Jill Daugherty, MPH - Emory
Deja Er, MPH - Emory
Linda Felix, MAT - Emory
Meklit Hailemeskal, MPH - Emory
Toya Howard - Emory
Tamika Hoyte, MPH - Emory
Jamie Smith, MPH - Emory
Lisa Smith, MPH - Emory
Les DeMorst - UCLA
Rotrease Regan, RN, MPH - UCLA
Elsa Rogers - UCLA
Karen Carter - Penn
Calvin Collier, BS - Penn
Mikia Croom, BS - Penn
Dionna Samuel, MS - Penn
Joseph Sosa, BS - Penn
Brian Taylor, BS - Penn
Supervisors Tamara S. Bryan, PhD - Columbia
LaShun Robinson-Simpson, PhD - Emory
Christina Camp, PhD - Emory
Tamra Loeb, PhD - UCLA
John Williams MD - UCLA
Lynette Gueits, MPH - Penn
Laboratory Cynthia Bayer, MS, CRNP - Penn
Angela Caliendo, MD, PhD - Emory
Shalonda Freeman, PhD - Emory
Jessica Ingersoll - Emory
Lisa Maslankowski, MD - Penn
Debra McGee-Smith, NP - UCLA
Patrice Moorer, MS - Emory
Michelle Mott, MSN, FNP-C - Emory
Bennie Woodard, MPH - Emory
Data Collectors Claudette Bannerman - Columbia
Warren Blake - Columbia
Tiffany Bratts MPH - Columbia
Olivia Copeland, Ed.D - Columbia
Daisy De Jesus-Sosa - UCLA
Adefunke Faly, MPH - Emory
Meklit Hailemeskal, MPH - Emory
Tamika Hoyte, MPH - Emory
Janet Hsu, BS - Penn
Heather Irobunda - Columbia
Shakaria Johnson, MPH - Emory
Frandy Napoleon - Columbia
Karen Williams - UCLA
Sonya Combs, MS - Penn
Mathew MacDonald, BS - Penn
Lolita Roy MSSW - Columbia
Dalena White, MBA - Penn
Pandora Woods, BS - Penn
Crystal Wyatt - Penn
1024 AIDS Behav (2010) 14:1023–1031
123
relationship in the past year. Of the 4,389 that were pre-
screened, 1,472 individuals were further screened and
provided consent for study participation, and 93% (1,374)
met the study eligibility criteria. Baseline ACASI data,
including demographic characteristics, were collected for
1,178 participants (85% of all eligible individuals); 1,070
(78% of those who were eligible) of these participants were
subsequently randomized and 108 were not.
Study Design
The Eban study is a two-arm, couples-based randomized con-
trolled trial of high-risk HIV serodiscordant African American
couples currently underway in four cities in the US. The present
article examines the baseline behavioral and biological data
collected from this cohort of eligible couples. Study enrollment
opened in November 2003 and closed in June 2007. Participants
were 535 couples enrolled across four urban metro areas, where
high-risk serodiscordant African American couples could be
recruited (Atlanta = 117 couples; Los Angeles = 100 cou-
ples; New York = 221 couples; Philadelphia = 97 couples).
Bellamy [11] contains a complete description of the randomi-
zation procedure implemented in this trial.
Data Collection
At baseline, data were obtained from three sources. First,
participants completed a 90-min Audio Computer-Assisted
Survey Interview (ACASI), which assessed sociodemo-
graphic characteristics, HIV/STD-associated sexual behav-
iors, and psychosocial mediators that had sound psychometric
properties and had previously been implemented with adult
African American populations. Although both male and
female partner participants completed the same ACASI
assessments, the sexual behavior items were written to be
appropriate for each gender. Subsequently, a trained African
American interviewer administered validated and reliable
assessments on sexual and physical abuse and a brief index
assessing study participants’ commitment to the African
American community. Finally, males provided a urine spec-
imen and women provided two self-obtained vaginal swab
specimens that were assayed for three STDs.
Assessment of STDs
STD prevalence was defined as a laboratory-confirmed test
for chlamydia, gonorrhea, or trichomonas infection at the
baseline assessment. Participants were considered STD
positive if they tested positive for any one of these three
STDs. One swab was evaluated for Neisseria gonorrhoeae
(GC) and Chlamydia trachomatis (CT) using the Becton–
Dickinson ProbeTec ET Chlamydia trachomatis and Neis-
seria gonorrhoeae Amplified DNA Assay (Sparks, MD). A
second vaginal swab was tested for Trichomonas vaginalis
(TV) using Taq-Man PCR [12]. All assays were conducted at
the Emory University Department of Pathology Research
Laboratory. Participants testing positive for an STD were
provided directly observable single-dose treatment and
received appropriate counseling per CDC recommendations.
Assessment of Self-Report Measures
Sociodemographic Characteristics
Sociodemographic characteristics assessed included par-
ticipant’s age, education, employment status, income,
health insurance, marital status and number of years with
study partner.
Medical History
Participants reported their last CD4 count, last viral load,
length of time since their HIV diagnosis (months), whether
they had a history of hepatitis C, and whether they had ever
received drug treatment.
Sexual Behaviors
Participants provided data on types of sexual behaviors
engaged in (vaginal, anal and oral), frequency of male or
female condom use during sex, whether behaviors were
practiced with their study partners, with partners outside this
primary relationship or with both, and data were reported
across three different time periods (at last sex, past 30 days
and past 90 days). Shorter time frames were selected to
facilitate the collection of more reliable reports of episodes
of sexual behavior [13] while longer time frames allowed
capturing a greater number of episodes of sexual behavior.
The primary HIV sexual risk behaviors assessed have been
used in prior multisite studies involving African Americans
and individuals living with HIV, and this study used similar
measures for consistency of assessment [14, 15].
The primary HIV sexual risk behavior assessed was the
proportion of the participants’ vaginal and anal intercourse
episodes with their study partner in the past 90 days that
were protected using a male or female condom. This var-
iable was calculated by dividing the total number of epi-
sodes of vaginal and anal intercourse with the study partner
in the past 90 days into the total number of times a male or
female condom was used on those occasions. Similar
variables were created to assess proportion of oral and anal
sexual episodes protected by a condom in the past 90 days
The NIMH Multisite HIV/STD Prevention Trial for African
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with the study partner. Additionally, similar variables were
computed to assess proportion of protected vaginal, anal or
oral episodes with partners other than the study partner in
the past 90 days that were protected using a condom.
A second important HIV sexual risk behavior assessed
was the number of unprotected vaginal intercourse episodes
with the study partner in the past 90 days. This variable was
calculated by subtracting the total number of vaginal inter-
course episodes with the study partner with whom a condom
was used in the past 90 days from the total number of epi-
sodes of vaginal intercourse with the study partner in the past
90 days. Similar variables were created to assess number of
oral and anal sexual episodes not protected by a condom in
the past 90 days with the study partner. Additionally, similar
variables were computed to assess number of unprotected
vaginal, anal or oral episodes with partners other than the
study partner in the past 90 days.
Sexual behaviors with concurrent partners was assessed by
asking each member of the couple if he or she had sex with
someone other than his or her study partner in the past 90 days
and whether condoms were used on those occasions. The
assessment also measured history of trading sex for drugs,
shelter, money or food in the past 90 days and reported con-
dom use (male and female condoms) at last sexual episode
(vaginal, anal, and oral sex) with study partners.
Psychosocial Variables
Psychological distress was measured using the Center for
Epidemiologic Studies—Depression (CESD) Scale (Brief
version) [16]. Adult sexual abuse (ASA) was assessed using
the Wyatt Sex History Questionnaire (Adult Sexual Abuse
section only) [17] and intimate partner violence (IPV) was
assessed using the Revised Conflict Tactics Scale (CTS2),
modified version [18] which measures the history of phys-
ical abuse by an intimate partner in adulthood. The Cutting
down, Annoyance by criticism, Guilty feeling and Eye-
openers (CAGE) brief screener was used to measure lifetime
alcohol dependence [19] and history of heavy drug use and
dependence was measured using the Texas Christian Drug
Screen II (TCUDS) [20]. Alcohol and drug problems were
characterized by CAGE scores greater than or equal to 2 and
by TCUDS scores greater than or equal to 3, respectively.
History of spending time in a drug treatment program was
assessed by the following item: ‘‘Have you ever spent time
in an impatient drug treatment program?’’ and douching
(females only) was assessed by the following question: ‘‘In
the past 90 days, have you douched?’’
Statistical Analysis Methods
Descriptive summaries were calculated for sociodemo-
graphic characteristics and sexual behaviors, and appropriate
independent two-sample methods were employed to com-
pare couples in which the female partner was HIV positive
with couples in which the male partner was HIV positive.
Gender-specific comparisons for select variables were also
computed (e.g., comparing females in couples where the
HIV positive partner was female to males in couples where
the HIV positive partner was male). Means and standard
deviations were computed for continuous measures, and t-
tests were calculated with corresponding P-values of the null
hypothesis that population means were identical in the two
groups (couples in which the female was the positive partner
compared with couples in which the male was the positive
partner). Similarly, frequency and percents were calculated
for categorical measures, and corresponding chi-squared
(v2) tests were computed to test the null hypothesis of no
association in the distribution of those frequencies in couples
in which the female was the positive partner compared with
couples in which the male was the positive partner. All
analyses were completed using SAS V9 [21]. Univariate
analyses of categorical and continuous variables were
performed using the FREQ, MEANS or UNIVARIATE
procedures, as appropriate, and all hypotheses tests were
two-sided and conducted at the alpha = 0.05 level.
Couple-Level Measures
A couple-level STD measure was created as the cross-classi-
fication (similarity of the partners’ STD status versus dissimi-
larity of the partners’ STD status) of each partner’s
dichotomous STD outcome noting whether both partners tested
positive, one partner tested positive, or both partners tested
negative for any one of the three STDs. Similarly, dichotomous
couple-level sexual behavior measures (e.g., condom use at last
sex, history of trading sex) were also cross-classified as simi-
larity of partners’ responses versus dissimilarity of partners’
responses. Finally, continuous couple-level sexual behavior
measures were also computed. For example, the proportion of
vaginal intercourse episodes using a male condom in the past
90 days reported by the couple was calculated for each study
partner as described above. Subsequently, the couple-level
variable was derived by adding the individual-level data and
averaging partner-specific individual-level data.
Results
Sociodemographic Characteristics of the Sample
Table 1 compares the sociodemographic characteristics of
participants and those who were eligible but not random-
ized. Participants were more likely to be married (33 vs.
20%; v2 = 6.96 (df = 2), P = 0.0084), than eligible non-
participants, however, there were no observed age,
1026 AIDS Behav (2010) 14:1023–1031
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education, income, insurance status, or employment status
differences between participants and those who were eli-
gible but not randomized.
The CD4 counts and viral load of HIV positive indi-
viduals were also assessed. Thirty-six percent of HIV
positive males (n = 74) and 28% of HIV positive females
(n = 89) reported not knowing their CD4 count and 48%
of HIV positive males (n = 98) and 44% of HIV positive
females (n = 136) reported not knowing their viral loads.
Of the reported values, there were no differences in the
distribution of viral loads for HIV positive males and
females (v2 = 1.60 (df = 3), P = 0.6601), however, the
reported distribution of CD4 counts were significantly
different. Specifically, the distribution of CD4 counts
(copies/mL) for HIV positive women was 7% reported 0–
200; 31% reported 201–500 and 33% reported [500
compared to HIV positive men: 12% reported 0–200; 24%
reported 201–500 and 28% reported [500 (v2 = 8.15
(df = 3), P = 0.0430).
Prevalence of Sexual Risk Behaviors
Table 2 compares the baseline prevalence of the study
couples’ sexual risk behaviors. Couples in which the HIV
positive partner is female were compared to couples in
which the HIV positive partner is male with respect to each
outcome and sexual risk behavior. However, couples with
HIV positive male partners reported a significantly higher
proportion of condom-protected sex than couples with HIV
positive female partners (mean = 0.54, SD = 0.39 versus
mean = 0.38, SD = 0.38; t = -4.60 (df = 530), P \
0.0001). All couples reported similar frequencies of
unprotected sexual activity (vaginal, anal and oral) with
their study partners in the past 90 days. Couples with HIV
positive female partners reported a significantly higher
(t = 4.68 (df = 478), P \ 0.0001) proportion of male
condom-unprotected vaginal sex (mean = 0.64; SD =
0.36) compared with couples with HIV positive male
partners (mean = 0.48; SD = 0.38). Few couples reported
using the female condom during sex.
The prevalence of sexual risk behaviors with partners
outside of the couple’s relationship (e.g., concurrent part-
ners) were similar among couples with HIV positive female
and couples with HIV positive male partners. Specifically,
significant differences were not reported in the prevalence of
the couples’ prior history of trading sex for drugs, money,
shelter or food (v2 = 2.24 (df = 2), P = 0.3261); the
number of concurrent opposite sexual partners (v2 = 0.14
(df = 2), P = 0.9329); the proportion of male-condom
unprotected vaginal sex episodes in the past 90 days
(t = 0.54 (df = 6), P = 0.6102); or the frequency of
unprotected vaginal sex episodes with opposite sex partners
in the past 90 days (t = -2.04 (df = 6), P = 0.1269).
STD Prevalence
The prevalence of STDs was also assessed at the couple
level. Twenty-three percent (n = 74) of couples with HIV
positive female partners and 26% (n = 56) of couples with
HIV positive male partners (v2 = 0.33 (df = 1), P =
0.5680) tested positive for at least one STD at baseline
(e.g., at least one partner tested positive for at least one
STD). Further analyses assessed STD prevalence at the




All values represent N (%).
P-values were determined
using v2 tests
df degrees of freedom
a P-value \0.01, b P-value
\0.10
Eligible and
randomized (n = 1070)
Eligible and not
randomized (n = 108)
v2 statistic
Age
\30 60 (5.69) 4 (3.96) 2.23, df = 2
30–39 229 (21.71) 28 (27.72)
40? 766 (72.61) 69 (68.32)
Married to study partnera 344 (32. 54) 20 (19.80) 6.95, df = 1
Education
\HS 325 (30.72) 33 (32.67) 0.47, df = 2
HS/GED 435 (41.12) 38 (37.62)
Some college 298 (28.17) 30 (29.70)
Employedb 300 (28.41) 37 (36.63) 3.02, df = 1
Income
\$400 per month 307 (29.10) 32 (32.00) 1.02, df = 3
$400–850 per month 443 (41.99) 37 (37.00)
$851–1650 per month 204 (19.34) 20 (20.00)
[$1650 per month 101 (9.57) 11 (11.00)
Insured 796 (75.38) 81 (80.20) 1.17, df = 1
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that STDs, were significantly more prevalent in women
than in men (v2 = 74.60 (df = 1), P \ .0001). This dif-
ference in STD prevalence by gender was accounted for by
Trichomoniasis. The prevalence of gonorrhea, Trichomo-
niasis and chlamydia was similar for HIV positive and HIV
negative females. However, when comparing the preva-
lence of each STD for the HIV positive and HIV negative
males, HIV negative males had a higher STD prevalence
(7.19 vs. 2.37%; v2 = 5.91 (df = 1), P = 0.0150)
(Tables 3, 4).
Bivariate and Multivariate Associations
for STD Prevalence in Women
Bivariate associations were assessed between sociodemo-
graphic characteristics, sexual behaviors, psychosocial
factors, and the variable ‘‘any STD,’’ defined as testing
positive for at least one STD at baseline. In bivariate
analyses conducted among women (n = 535) who were
either HIV positive or HIV negative, being uninsured
(v2 = 1.97 (df = 1), P = 0.1608), having a lengthier
Table 2 Baseline prevalence of couple-level HIV transmission sexual risk behaviors, by gender of HIV sero-positive partner (within the
relationship in the past 90 days)
HIV ? female couples (n = 323) HIV ? male couples (n = 212) Statistic, df
Proportion condom protected sexa 0.38 ± 0.38 0.54 ± 0.39 -4.60, df = 530
MC at last vaginal sexb
Both no 36 (11.25) 33 (15.79) 9.68, df = 2
One no 262 (81.88) 148 (70.81)
Both yes 22 (6.88) 28 (13.40)
MC at last anal sex
Both no 17 (27.87) 8 (22.22) 0.38, df = 2
One no 38 (62.30) 24 (66.67)
Both yes 6 (9.84) 4 (11.11)
FC at last vaginal sex
Both no 19 (5.94) 19 (9.05) 2.77, df = 2
One no 284 (88.75) 176 (83.81)
Both yes 17 (5.31) 15(7.14)
# Unprotected vaginal sex (w/ study partner)
MC unprotected 16.69 ± 22.68 14.69 ± 27.16 0.83, df = 329
FC unprotected 25.20 ± 29.28 25.41 ± 29.36 0.18, df = 504
Neither MC or FC 17.32 ± 23.14 14.89 ± 24.00 1.03, df = 425
# Unprotected anal sex (w/ study partner)
MC unprotected 3.09 ± 3.87 2.90 ± 4.36 0.17, df = 59
FC unprotected 5.21 ± 6.80 4.10 ± 5.05 -0.45, df = 504
Neither MC or FC 3.50 ± 4.32 2.50 ± 3.80 0.84, df = 46
# Unprotected oral sex (receptive, w/ study partner)
DD or MC unprotected 13.86 ± 30.37 13.39 ± 16.44 0.16, df = 240
# Unprotected oral sex (non-receptive, w/ study partner)
DD or MC unprotected 12.18 ± 18.63 12.03 ± 14.03 0.06, df = 204
Proportion unprotected vaginal sex (w/ study partner)
MC unprotecteda 0.64 ± 0.36 0.48 ± 0.38 4.68, df = 478
FC unprotectedc 0.96 ± 0.12 0.94 ± 0.16 1.74, df = 312
Neither MC or FCd 0.66 ± 0.36 0.51 ± 0.38 3.92, df = 425
Proportion unprotected anal sex (w/ study partner)
MC unprotected 0.57 ± 0.36 0.63 ± 0.36 -0.72, df = 59
FC unprotected 0.88 ± 0.19 0.95 ± 0.15 -1.36, df = 59
Neither MC or FC 0.63 ± 0.36 0.66 ± 0.39 -0.28, df = 46
Values shown are N (%) or mean ± standard deviation. P-values for continuous variables were determined using two-sample t-tests; P-values for
categorical variables were determined using v2 tests
STD sexually transmitted disease, MC male condom, FC female condom, DD dental dam
a P-value \0.0001; b P-value \0.01; c P-value \0.10; d P-value \0.001
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relationship with one’s study partner (t = -1.48
(df = 527), P = 0.1396), and having a history of douching
(v2 = 13.11 (df = 1), P = 0.0003), inpatient drug treat-
ment (v2 = 1.89 (df = 1), P = 0.1692) or abuse
(v2 = 1.65 (df = 1), P = 0.1996), were associated with
testing positive for at least one STD at baseline. In multi-
variate analyses, women who douched were 2.28 times as
likely to have a prevalent STD (odds ratio [OR] = 2.28;
95% confidence interval [CI], 1.40–3.74; v2 = 10.85
(df = 1), P = 0.0010). No other variables were significant
in this multivariate model.
Bivariate and Multivariate Associations
for STD Prevalence in Men
Bivariate associations were assessed between sociodemo-
graphic characteristics, sexual behaviors, psychosocial
factors, and the variable ‘‘any STD,’’ defined as testing
positive for at least one STD at baseline. In bivariate
analyses conducted among men (n = 535) who were either
HIV positive or HIV negative, being uninsured (v2 = 6.33
(df = 1), P = 0.0119) and having a history of PTSD
(v2 = 2.61 (df = 1), P = 0.1061) were associated with
testing positive for at least one STD at baseline. In multi-
variate analyses, men who were uninsured were approxi-
mately 2.6 times as likely to have a prevalent STD
(OR = 2.62; 95% CI, 1.22–5.65; v2 = 6.03 (df = 1),
P = 0.0140). Insurance status was the only variable sig-
nificant in this multivariate model.
Discussion
This study is among the first to examine HIV serodiscor-
dant African American couples. Serodiscordant couples
who engage in unprotected sexual activity are an important
research focus because they are in relationships where the
risk of transmission is very high. This study makes sig-
nificant contributions to public health research because it
highlights a population that has received scant empirical
attention. HIV has permeated our society and remains a
significant public health problem. It affects not only indi-
viduals, but also families.
Besides being affected by HIV, these couples are
affected by other sexual risks. Overall, couples reported
using condoms only about 44% of the time when they had
anal or vaginal sex. Furthermore, the proportion of condom
protected sexual episodes were significantly less frequent
when the female partner was positive compared to when
the male partner was HIV positive. This pattern was
observed among females in sexual relationships with their
study partner as well as with their nonstudy partners,
suggesting that if the female partner is the positive partner
in a serodiscordant couple negotiating safer sex may be a
challenge. Strategies for reducing HIV transmission risk in
HIV serodiscordant couples need to take into account the
gender of the HIV positive partner, given greater potential
for transmission when the female partner is positive.
Additional HIV transmission behaviors, including high
levels of non-condom use, were reported by at least one
member of many study couples. Nearly 18% of couples
reported that one partner had a concurrent sexual partner,
and about 8% of couples reported that at least one partner
had traded sex for money, drugs, or food. Clearly, given the
breadth of HIV transmission risk behaviors reported by
couples in this study, prevention efforts tailored to this
subpopulation are warranted.
About 26% of the couples tested positive for an STD.
The prevalence of STDs reported among this sample is
comparable to the prevalence reported in other studies of
HIV positive individuals [22]. By far the most prevalent
STD in females and in males was Trichomonas. Prevalence







Chlamydia 4 (0.75) 4 (0.75) 8 (0.75)
Gonorrhea 0 (0.00) 1 (0.19) 1 (0.09)
Trichomoniasis 24 (4.52) 116 (21.80) 140 (13.17)
Any STDa 28 (5.27) 120 (22.51) 148 (13.91)
Values shown are N (%) aGeneralized Cochran Mantel Haensel
(CMH) test statistic; v2 = 74.60, df = 1, P \ 0.0001
Table 4 STD prevalence among females and males by HIV serostatus
Females Males
HIV- HIV? All HIV- HIV? All
(n = 212) (n = 323) (n = 535) (n = 323) (n = 212) (n = 535)
Chlamydia 2 (0.94) 2 (0.62) 4 (0.75) 4 (1.25) 0 (0.00) 4 (0.75)
Gonorrhea 0 (0.00) 1 (0.31) 1 (0.19) 0 (0.00) 0 (0.00) 0 (0.00)
Trichomoniasis 53 (25.00) 63 (19.69) 116 (21.80) 19 (5.94) 5 (2.37) 24 (4.52)
Any STD 55 (25.94) 65 (20.25) 120 (22.51) 23 (7.19) 5 (2.37) 28 (5.27)
Values shown are N (%)
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rates for Trichomonas were comparable for HIV negative
and for HIV positive females. The comparable prevalence
of STDs in HIV negative and HIV positive women has
been documented in prior research [7]. However, signifi-
cantly more HIV negative males had a prevalent Tricho-
monas infection compared with HIV positive males.
Trichomonas is a protozoan parasite transmitted princi-
pally through vaginal intercourse and is highly prevalent in
African Americans. Empirical research suggests that
Trichomonas may play an important role in HIV trans-
mission dynamics [23]. Trichomonas typically elicits an
aggressive local cellular immune response with inflam-
mation of the vaginal epithelium and exocervix in women
and the urethra in men [24]. This inflammatory response
induces a large infiltration of leukocytes, including HIV
target cells such as CD4? bearing lymphocytes and mac-
rophages to which HIV can bind and gain access [25]. In
addition, Trichomonas can frequently punctuate mucosal
hemorrhages [26]. Among persons living with HIV, the
pathology induced by Trichomonas can increase HIV
shedding. Trichomonas infection may also act to expand
the portal of entry for HIV in an HIV negative person [27].
In multivariate analyses, the only significant correlate of
having a prevalent STD in women was douching. Histori-
cally, vaginal douching has been used as a hygienic prac-
tice [28], and several studies have reported that douching is
more common among African American women compared
with women of other ethnic groups [29–31]. African
American women may douche more frequently as a result
of cultural beliefs reinforcing douching as a hygienic
practice as well as possibly an effective contraceptive
practice [32, 33]. Douching has been found to reduce the
normal vaginal flora, specifically, the Lactobacilli bacteria
that protect against genital pathogens. This may result in an
overgrowth of pathogenic organisms in the lower genital
tract [34]. A study conducted by McClelland et al. among
Kenyan women demonstrated that vaginal washing with
water or soap increased women’s risk for acquiring HIV-1
[35]. This study concluded that intervention strategies
aimed at modifying intravaginal practices should be eval-
uated as a possible female-controlled HIV-1 prevention
strategy.
In multivariate analyses with males, being uninsured
was the only significant correlate of having a prevalent
STD. Socioeconomic forces such as having limited health
insurance are well-known risk markers for HIV and other
STIs [36, 37]. This finding contributes to the accumulating
evidence which emphasizes the importance of social and
economic context in promoting the spread and perpetuation
of the HIV epidemic among African Americans. Changing
the social context of life for African Americans may be
effective in decreasing the burden of the HIV epidemic in
this community [38].
Strengths and Limitations
This study has a number of limitations. The sample in this
study may not be representative of all African American
serodiscordant couples. To be eligible to participate, a
couple had to have been together for 6 months, be planning
to be together another year, and have no plans to have a
child. The results may not generalize to couples that do not
meet these criteria. Moreover, these eligibility criteria may
have hampered our ability to identify other known corre-
lates of STD prevalence in African Americans. Addition-
ally, we did not recruit people who were unaware that they
were in a serodiscordant relationship, which restricts the
generalizability of the findings.
The data from this study represent a significant exten-
sion in the examination of couple-level HIV sexual risk
behavior. The findings are original and contribute signifi-
cantly to HIV/STD research with couples, particularly
African American couples. Additionally, presentation of
the sociodemographic characterization and HIV risk
behavior profiles of African American HIV serodiscordant
couples represents an important initial description of a
hidden, vulnerable population.
In conclusion, because of HIV infection, individuals in
serodiscordant couples need to learn to have sex in a way
that is safe and healthful for both themselves and their
partners. Programs that provide information and skills to
promote sexual health in the context of couples’ lives and
the fullness of their relationships have the potential to be
successful in reducing the risks that HIV serodiscordant
couples face. Future research should be conducted with
diverse samples of African American couples (i.e., younger
couples, non-stable couples) to explore other potential
correlates of STD prevalence.
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